×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| JUBILANT PHARMOVA LIMITED | 2144 | 53 | 1960 | 0.33 | 15,404 | 46.2 |
| NATCO PHARMA LTD. | 6,511.00 | 1,324.00 | 4,748.00 | 7.43 | 14292 | 7.67 |
| NEULAND LABORATORIES LTD. | 4019.37 | 1015.87 | 3980.32 | 79.18 | 14107 | 58.8 |
JUBILANT PHARMOVA LIMITED, with Security Code 530019, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 222.9 | 182.7 | 199.8 | 217.4 | 186.3 | 175.2 | 205.8 | 166.7 | 165.7 | 196.0 |
| Expenses | 215.7 | 184.6 | 197.7 | 213.2 | 185.5 | 175.9 | 193.6 | 165.5 | 171.8 | 185.0 |
| Operating Profit | 7.3 | -1.9 | 2.2 | 4.2 | 0.8 | -0.7 | 12.2 | 1.2 | -6.1 | 11.0 |
| OPM % | 3.27% | -1.03% | 1.09% | 1.93% | 0.43% | -0.4% | 5.93% | 0.72% | -3.68% | 5.61% |
| Other Income | 106.1 | 7.9 | 13.7 | 15.9 | 18.4 | 19.0 | 50.1 | 8.3 | 43.8 | 18.4 |
| Interest | 4.1 | 5.5 | 5.7 | 6.4 | 7.1 | 8.3 | 8.1 | 7.6 | 7.8 | 7.4 |
| Depreciation | 11.1 | 11.6 | 11.4 | 11.4 | 11.9 | 12.3 | 12.7 | 13.1 | 13.3 | 13.3 |
| Profit before tax | 98.2 | -11.1 | -1.2 | 2.3 | 0.2 | -2.3 | 41.5 | 0.0 | 16.6 | 8.7 |
| Tax % | 6.5% | -47.1% | -2408.9% | 17.4% | 300% | -4.3% | 21.7% | -8.9% | 36.7% | 39.1% |
| Net Profit | 91.8 | -5.9 | -30.9 | 1.9 | -0.4 | -2.4 | 32.5 | -10.2 | 10.5 | 5.3 |
| EPS in Rs | 5.77 | -0.37 | -1.94 | 0.12 | -0.03 | -0.15 | 2.05 | -0.64 | 0.66 | 0.33 |
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,440.5 | 1,599.5 | 1,552.5 | 1,678.0 | 1,586.9 | 1,680.3 | 1,677.1 | 175.9 | 1,731.7 | 1,752.3 |
| Expenses | 1,259.5 | 1,383.4 | 1,408.3 | 1,458.8 | 1,418.7 | 1,438.5 | 1,459.1 | 148.7 | 1,480.2 | 1,463.0 |
| Operating Profit | 181.0 | 216.1 | 144.2 | 219.2 | 168.2 | 241.8 | 218.0 | 27.1 | 251.5 | 289.3 |
| OPM % | 12.6% | 13.5% | 9.3% | 13.1% | 10.6% | 14.4% | 13% | 15.4% | 14.5% | 16.5% |
| Other Income | 22.6 | -43.7 | 9.5 | 4.5 | 8.6 | 9.9 | 35.8 | -15.5 | 14.0 | 7.5 |
| Interest | 39.9 | 42.0 | 50.7 | 55.6 | 61.9 | 66.1 | 71.3 | 7.3 | 71.0 | 61.0 |
| Depreciation | 94.6 | 94.0 | 94.3 | 271.2 | 89.7 | 96.6 | 94.6 | 10.1 | 90.7 | 91.4 |
| Profit before tax | 69.1 | 93.2 | 8.7 | -103.1 | 25.2 | 89.0 | 87.9 | 11.2 | 103.8 | 158.6 |
| Tax % | 32.2% | 80.6% | 238.6% | -13.7% | 72.2% | 40.3% | 39.4% | -14.2% | 3.6% | 29% |
| Net Profit | 46.8 | 4.9 | -16.0 | -100.5 | 6.0 | 62.1 | 66.4 | -6.2 | 481.8 | 102.5 |
| EPS in Rs | 2 | 0 | 0 | -6 | 0 | 3 | 4 | -3 | 30 | 6 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | -26% |
| 3 Years: | -34% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -18% |
| 5 Years: | -27% |
| 3 Years: | -47% |
| TTM: | 256% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 15% |
| 3 Years: | 32% |
| 1 Year: | 65% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -6% |
| 3 Years: | 3% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | -44% |
| 3 Years: | -64% |
| TTM: | 810% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 15% |
| 3 Years: | 32% |
| 1 Year: | 65% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|